China Is Collecting DNA From Tens of Millions of Men and Boys, Using U.S. Equipment
By Sui-Lee Wee,
The New York Times
| 06. 17. 2020
Even children are pressed into giving blood samples to build a sweeping genetic database that will add to Beijing’s growing surveillance capabilities, raising questions about abuse and privacy.
The police in China are collecting blood samples from men and boys from across the country to build a genetic map of its roughly 700 million males, giving the authorities a powerful new tool for their emerging high-tech surveillance state.
They have swept across the country since late 2017 to collect enough samples to build a vast DNA database, according to a new study published on Wednesday by the Australian Strategic Policy Institute, a research organization, based on documents also reviewed by The New York Times. With this database, the authorities would be able to track down a man’s male relatives using only that man’s blood, saliva or other genetic material.
An American company, Thermo Fisher, is helping: The Massachusetts company has sold testing kits to the Chinese police tailored to their specifications. American lawmakers have criticized Thermo Fisher for selling equipment to the Chinese authorities, but the company has defended its business.
The project is a major escalation of China’s efforts to use genetics to control its people, which had been focused on tracking ethnic minorities and...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...